Cell migration is regulated by focal adhesion (FA) turnover. Fibroblast growth factor-2 (FGF-2) induces FA disassembly in the murine brain capillary endothelial cell line, IBE, leading to FGF-2-directed chemotaxis. We previously showed that activation of Src and Fes by 
Introduction
Angiogenesis is a prerequisite for both normal development as well as pathophysiological processes, such as collateral formation following occlusion of arteries, diabetic retinopathy, and solid tumor growth [1] [2] [3] . A number of endothelial cell responses must be integrated for efficient angiogenesis, including proliferation, differentiation and migration [4] . Cell migration is coordinated by signaling events involving both growth factor receptors and integrins [5] [6] [7] . Many studies have emphasized the contribution of dynamic assembly and disassembly of focal adhesions to this response. Although multiple signaling molecules are incorporated within focal adhesions (FA), focal adhesion kinase (FAK) and Src play fundamental roles in focal adhesion turnover [8] [9] [10] .
Fibroblast growth factors (FGFs) are important regulators of angiogenesis both in vitro and in vivo [11, 12] . To date, 23 distinct forms of FGF have been identified [13] .
Prototypical FGFs, such as FGF-1 and FGF-2, are the most thoroughly studied FGFs in relation to angiogenesis. Four structurally-related receptor tyrosine kinases for FGFs have been reported, denoted FGF receptors (FGFR) 1 to 4 [14] . Of these, both FGFR-1 and 2 are expressed in endothelial cells, where they induce Src activation and chemotaxis [15] [16] [17] . Src has also been implicated in FGF-regulated migration and proliferation of fibroblasts [18] [19] [20] .
We have previously shown that Fes, a non-receptor protein tyrosine kinase distinct from Src, also contributes to FGF-2-induced chemotaxis and differentiation of capillary endothelial cells [21] . In this study, we provide evidence that Fes activity is required for FGF-2-induced activation of Src and focal adhesion disassembly, providing the first mechanistic link between these protein-tyrosine kinases in FGF-induced regulation of vascular endothelial cell behavior. 
Materials and methods

Materials
Immunoprecipitation and immunoblotting
Immunoprecipitation and immunoblotting were performed as described before [22] .
In brief, cells suspended in serum-free medium were seeded onto fibronectin-coated dishes and cultured for various periods in the presence or absence of 20 ng/ml of FGF-2. Cells were lysed in Triton X-100 lysis buffer and kinase or focal adhesion proteins were immunoprecipitated and separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). After transfer onto polyvinylidene difluoride membranes (Millipore, Bedford, MA), the blots were probed with antibodies as indicated in the Figures. Prior to reprobing, blots were stripped as described previously [21] . For the FAK blots, band intensities were determined from scanned images of the blots using NIH Image (version 1.64). The relative ratio of FAK tyrosine phosphorylation was calculated as the ratio of the phospho-FAK signals divided by the corresponding FAK protein signal; each value was then normalized to the ratio obtained from untreated, suspended cells.
Indirect immunofluorescent staining
Indirect immunofluorescent staining was performed as described previously [23] . 
In vitro kinase assay
The in vitro kinase assay for Src was described previously [16] . In brief, cells were seeded onto fibronectin-coated wells of 6-well plates with or without 20 ng/ml FGF-2. After 2 h, cells were lysed in NP40 lysis buffer supplemented with 0.1% 2-mercaptoethanol. Src was immunoprecipitated and incubated in kinase buffer supplemented with acid-denatured enolase and [-32 P]ATP, followed by SDS-PAGE. Gels were washed, fixed, treated with 1 M KOH to remove phosphorylated serine residues, and imaged using a BAS 5000 Image Analyzer followed by exposure to X-ray film.
Statistical analysis
Data are presented as the mean ± SD. Differences between two groups were examined by Mann-Whitney's U test. A P value less than 0.05 denoted the presence of a statistically significant difference.
Results
FGF-2 induces disassembly of FA in IBE cells
We have previously shown that Fes activity was involved in FGF-2-directed chemotaxis of IBE cells [21] . FA disassembly is critical for cell migration, and FGF-2-treatment of IBE cells decreases the number of FA [23] . To elucidate the role of 
FGF-2 induces Src activation, which is dependent on Fes activity
To Ligation of integrins induces FAK autophosphorylation at Y397, which leads to its activation and creates a binding site for Src via its SH2 domain [8] . Binding to FAK may contribute to Src activation by disrupting the inhibitory interaction between its SH2 domain and tyrosine-phosphorylated tail [25] . Once bound and activated, Src phosphorylates FAK at Y861 [26] . To determine whether Fes affects the interplay of Src and FAK, we examined the kinetics of FAK activation and phosphorylation by Src in parental IBE cells and KE5-15 cells.
As shown in Fig. 3 , FAK was rapidly phosphorylated on Y397 following adhesion to fibronectin in control IBE cells, and phosphorylation of this site decreased 2 h after seeding. (Fig. 4 B) . We also determined the specificity of immunofluorescent staining with the Src phosphospecific antibody, pY418. Our previous study has shown that FGF-2 activated Src within FA, which was followed by the activation of 
Discussion
In this study, we provide new evidence that the c-Fes tyrosine kinase may regulate FA turnover in IBE capillary endothelial cells by modulating Src and FAK signaling. Several previous studies have established that oligomerization is essential for the kinase and biological activities of c-Fes. Importantly, kinase-dead Fes has been shown to form mixed oligomers with wild-type Fes and suppresses its autophosphorylation [27] . Directly relevant to this study is our prior observation that expression of kinase-inactive Fes abolished FGF-2-induced autophosphorylation of endogenous Fes in IBE cells, suggesting that kinase-inactive Fes oligomerized with endogenous Fes leading to the blockade of FGF-2-directed chemotaxis in this system [21] . Experiments with a dominant-negative mutant provide evidence that Fes activity is required for Src activation by FGF-2, which in turn regulates Src interaction with the FA protein p130 Cas (Fig. 2) . Perhaps most striking was the observation that targeted knock-down of Fes protein expression with siRNA almost completely blocked FGF-2-regulated Src activation within FA (Fig. 4) . The magnitude of this effect was virtually identical to that observed when FAK itself was suppressed with siRNA ( Fig. 5) .
In parental IBE cells, FAK activation (autophosphorylation of Y397) was observed 30 minutes after plating on fibronectin and was independent of FGF-2-treatment. This initial rapid activation was followed by dephosphorylation of this tyrosine residue at 2 h. In addition, we observed continuous, strong phosphorylation of Y861, a known phosphorylation site for c-Src on FAK (Fig. 3) . These kinetics are consistent with the finding that FAK activation leads to the recruitment and activation of Src by disruption of the intramolecular inhibitory interaction between its SH2 domain and C-terminal tail [25] . In contrast, maximal In summary, the present study emphasizes the significance of Fes in an important angiogenic response of endothelial cells, namely migration in response to FA disassembly. Fes also acts as a mediator of angiogenic stimuli promoted by angiopoietins, sonic hedgehog, and stromal cell-derived factor-1 [22, [28] [29] [30] . Fes may represent a previously unrecognized endothelial cell-specific molecular target for anti-angiogenic therapy. Antagonists of Fes kinase activity may block signals through these and other proangiogenic pathways.
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